Investors

News

August 10th, 2023 Biofarma announces completion of the acquisition of U.S. Pharma and the private placement of Senior Secured Notes due 2029

May 29th, 2023 Kepler S.P.A. Financial Results for Q1 2023

May 18th, 2023 Biofarma signs the acquisition of US Pharma Lab

May 4th, 2023 Kepler S.P.A. Financial Results for FY 2022

March 1st, 2023 Biofarma Group appoints Gianfranco Nazzi as new CEO

February 28th, 2023 General Manager Exit

November 28th, 2022 Kepler S.P.A. Financial Results for Q3 2022

September 29th, 2022 Biofarma Group financial calendar

September 27th, 2022 Kepler S.P.A. Financial Results for H1 2022

July 8th, 2022 Kepler S.P.A. Financial Results for Q1 2022

May 20th, 2022 Kepler S.P.A. announces the closing of the offering of its €345.0 million senior secured floating rate notes due 2029

May 6th, 2022 Pricing of Kepler S.p.A.’s €345.0 million senior secured floating rate notes due 2029

Annual Balance

• 2022 - Audit opinion – 29/04/2023
  Download
• Annual Consolidated Financial Report, 2022 – 29/04/2023
  Download

Quarter Reports

• Kepler Spa Interim Report 2023 - Q1 – 29/05/2023
  Download
• Kepler Spa Interim Report 2022 - Q3 – 28/11/2022
  Download
• Kepler Spa Interim Report 2022 – H1 – 27/09/2022
  Download
• Kepler Spa Interim Report 2022 – Q1 – 29/06/2022
  Download

Presentations and Documents

• Kepler SpA – Q1-23 Investor Presentation – 08/06/2023
  Download
• Kepler SpA – FY-22 Investor Presentation – 12/05/2023
  Download
• BNP Paribas Annual High Yield & Leveraged Finance Conference 2023 Presentation – 18/01/2023
  Download
• Kepler SpA – 3Q-22 Investor Presentation – 06/12/2022
  Download
• Kepler SpA – H1-22 Investor Presentation – 11/10/2022
  Download
• Kepler SpA – Q1-22 Investor Presentation – 14/07/2022
  Download